Increased formation of nucleotide derivatives of 5-fluorouridine in hepatoma cells treated with inhibitors of pyrimidine synthesis and D-galactosamine.
D000818:Animals; D001380:Azauridine / Q000494:pharmacology*; D001692:Biological Transport / Q000187:drug effects; D005260:Female; D005688:Galactosamine / Q000494:pharmacology*; D007700:Kinetics; D008114:Liver Neoplasms, Experimental / Q000378:metabolism*; D051381:Rats; D012265:Ribonucleotides / Q000096:biosynthesis*; D014529:Uridine / Q000031:analogs & derivatives* / Q000378:metabolism
D012265:Ribonucleotides; C001943:5-fluorouridine; D005688:Galactosamine; D001380:Azauridine; D014529:Uridine